Avenzo Deal History & Licensing Activity
Avenzo is a life sciences. Over the past three years, Avenzo has been involved in 1 licensing and acquisition transaction, with a primary focus on ADC (2 deals). The company currently has 4 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
1
Active Trials
4
Top Modality
ADC
Focus Area
Solid Tumors
Avenzo Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Avenzo in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| EGFR/HER3 bispecific ADC (BsADC) | Duality Biologics | ADC | Unknown | collaboration | Jun 2025 |
Avenzo Pipeline Focus
Therapeutic areas and modalities where Avenzo is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Avenzo Strategic Signals
Key indicators of Avenzo's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Avenzo Clinical Pipeline
Avenzo has 4 active clinical trials across 1 development phase.
4
Phase 1
See How Your Asset Matches Avenzo's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Avenzo Licensing & Deal Activity
Avenzo is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Avenzo ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Avenzo include Solid Tumors (4 deals and trials), and Women's Health (2 deals and trials). In terms of modality, Avenzo has shown particular interest in adc.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Avenzo and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Avenzo's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.